Page last updated: 2024-09-03

glycerophosphoinositol 4,5-bisphosphate and Syndrome

glycerophosphoinositol 4,5-bisphosphate has been researched along with Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Behr, E; Bendahhou, S; Cobo, AM; Donaldson, MR; Escolar, DM; Fu, YH; Jensen, JL; Mozaffar, T; Pereira, S; Poza, JJ; Ptácek, LJ; Suarez, WA; Szepetowski, P; Tawil, R; Tristani-Firouzi, M; Wagstaff, J1
Birk, OS; Elbedour, K; Hershkowitz, R; Landau, D; Manor, E; Narkis, G; Ofir, R; Volokita, M1
Bevers, EM; Comfurius, P; Schlegel, RA; Schroit, AJ; Sims, PJ; Smeets, EF; Weiss, HJ; Wiedmer, T; Williamson, P; Zhao, J; Zwaal, RF1

Other Studies

3 other study(ies) available for glycerophosphoinositol 4,5-bisphosphate and Syndrome

ArticleYear
PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome.
    Neurology, 2003, Jun-10, Volume: 60, Issue:11

    Topics: Abnormalities, Multiple; Arrhythmias, Cardiac; Binding Sites; Female; Genetic Predisposition to Disease; Humans; Male; Muscle Weakness; Mutation; Paralysis; Pedigree; Phenotype; Phosphatidylinositol 4,5-Diphosphate; Potassium Channels, Inwardly Rectifying; Syndrome

2003
Lethal contractural syndrome type 3 (LCCS3) is caused by a mutation in PIP5K1C, which encodes PIPKI gamma of the phophatidylinsitol pathway.
    American journal of human genetics, 2007, Volume: 81, Issue:3

    Topics: Alleles; Amino Acid Sequence; Amino Acid Substitution; Arthrogryposis; Asparagine; Aspartic Acid; Chromosomes, Human, Pair 19; Female; Homozygote; Humans; Male; Molecular Sequence Data; Mutation; Pedigree; Phosphatidylinositol 4,5-Diphosphate; Phosphotransferases (Alcohol Group Acceptor); Syndrome

2007
The complex of phosphatidylinositol 4,5-bisphosphate and calcium ions is not responsible for Ca2+-induced loss of phospholipid asymmetry in the human erythrocyte: a study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling.
    Blood, 1995, Sep-01, Volume: 86, Issue:5

    Topics: 4-Chloro-7-nitrobenzofurazan; Calcium; Erythrocyte Membrane; Erythrocytes; Hemophilia A; Humans; In Vitro Techniques; Kinetics; Lipid Bilayers; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Phospholipids; Reference Values; Syndrome; Thromboplastin

1995